Enter to open, tab to navigate, enter to select
Endo International PLC and DAVA Pharmaceuticals, Inc. merger
| June 24, 2014 • Private Acquisition Agreements • $575 million (subject to purchase price adjustment and additional earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.